Amwill Healthcare IPO: GMP, Date, Price & Details

Amwill Healthcare IPO-Complete Overview

Amwill Healthcare IPO under the SME IPO category is a book-build issue of Rs.59.98 Cr (54,03,600 Shares) by Amwill Healthcare Limited, which was incorporated in August 2017, The company is engaged in a derma-cosmetic development, working with distributors, contract manufacturers and third-party product development agencies. The partnership has enabled the organization to enhance its packaging, manufacturing, and distribution capabilities. 

Product Portfolio:

1. Development of generic dermatological solutions.

2. Formulating targeted solutions for dermatology problems.

The company sells its products mainly in Karnataka, Andhra Pradesh, and Telangana states, aiming to strengthen its foothold in these states before venturing into other markets to gain customer support.

The company develops products against dermatological disorders such as acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, sweating, trichology, and vitiligo.

 

Amwill Healthcare IPO Overview

This Amwill Healthcare IPO date is 05 February 2025, and its ‘initial public offering’ will end on 07 February 2025.    

This Rs.59.98 crore new SME IPO comprises a combination of a fresh issue of 44.04 lac Shares (Rs.48.88 Cr) and an offer for sale (OFS) of 10 lac Shares (Rs.11.10 Cr). 

This upcoming IPO date is on 05 Feb 2025. The Amwill Healthcare IPO Price is Rs.105 to Rs.111 for each Share. 

The expected IPO listing date is 12 Feb 2025, and the listing at BSE and SME.

 

The GMP of current IPOs can be viewed on our Live IPO GMP page, where you can get current SME IPO GMP of all open IPOs.

 

Click to open a Demat account  and apply for the IPO.

 

 

Company Financial

(Amount in Lac)

 

Cash Flows

The cash flows for various activities are mentioned below:

(Amount in Lac)

 

Product-wise Revenue Breakdown 

(Amount in Lac)

 

(Source: RHP)

The Objective of The Issue

• Financing the company's operating cash needs.

• Activities related to marketing and brand development.

• General corporate purposes.

 

Peers of Amwill Healthcare Ltd.

Evaluation

The IPO price is Rs.105 to Rs.111 for each Share.

Evaluation of P/E Ratio

Considering the FY ended 31 Mar 2024 with an EPS of Rs.8.04 from the last year, the resulting P/E ratio is 13.80x.

Considering the weighted EPS of Rs.4.96 for the last three years, the P/E ratio is 22.38x.

IPO's Strengths

• Wide range of products supported by formulation facilities.

• Partnerships with contract manufacturers and product prototype development houses for high-quality product development.

• Experienced management with proven skills in project management and implementation.

• Asset-light business model.

 

IPO’s Weaknesses

• Single Distributor Dependency - The firm's lines of income only come from M/s. Amderma Healthcare LLP acts as a carrying and forwarding agent for its products. This is a major risk since breaching this contract or failing to perform the agreement may have serious repercussions on business functions, profits, and cash flow.

• Liabilities regarding product regulation risks - The firm functions in a very vulnerable sector and is expected to meet stringent requirements of multiple state and central laws. Mostly, adverse regulatory conditions or even new rules may further complicate compliance and raise the cost burden affecting the business operations.

• Product Liabilities issues - Due to the kind of business that the firm undertakes, there are certain risks which are product liabilities which include product recalls due to contamination, defects, or product deterioration. These events will damage the company’s image, incur legal expenses, and the firm may be declared bankrupt due to these unprecedented losses.

• Inflation and Political Issues - The company looks at changes in inflation, interest rate changes, fiscal policies, and broad economic stability. Moreover, any modification of politics by the government or political violence may interfere with their operations and business growth negatively.

 

 

Amwill Healthcare IPO GMP 

Amwill Healthcare IPO GMP has not started yet as of 01 Feb 2025.

Amwill Healthcare IPO Timetable (Tentative)

The IPO date is February 05, with allotment on February 10, refund initiation on February 11, and listing on 12 February 2025.

 

Amwill Healthcare IPO Details 

The IPO with a Face Value of Rs.10 per share offers a total issue size of 54,03,600 Shares (Rs.59.98 Cr).

 

Amwill Healthcare IPO Lot Details 

The IPO allows retail investors to invest in a minimum and maximum of 1 Lot (1200 Shares) amounting to Rs.1,33,200 and in multiples thereof, while for HNI investors, the minimum Lot is 2 (2400 Shares) amounting to Rs.2,66,40

 

Amwill Healthcare IPO Reservation (% of Net Issue)

 

 

 

Promoters And Management of Amwill Healthcare Ltd.

• Anand Gandhi

• Tarun Gandhi.

 

IPO Lead Managers

• Unistone Capital Pvt Ltd.

Dividend Policy

The company has not declared a dividend in the last three years.

Conclusion

The Amwill Healthcare IPO showcases promising opportunities in the SME segment, with a chief focus on dermatology solutions. The company evidences strong financial growth, but risks remain in terms of dependency on distributors and regulatory hurdles. The investors should consider factors like the P/E ratio, the strengths of the company, and overall market conditions. 

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

DISCLAIMER: This is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions. 

 

Want to start Your Journey in stock market trading and investment? Join our Stock Market Class to become a beginner to expert trader! We cover everything from the basics of trading to advanced strategies for picking stocks. Plus, we're offering a special discount for women and students. Don't miss out - enroll now and kickstart your path to success in the stock market!
Open a world of Stock Market by Opening a Demat Account with your favorite Broking firm & Get a trading Strategy worth Rs.15,000!

Click here to open a Free Demat Account.

Thank You for reading this blog.
Hope you loved the IPO analysis.
Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.

Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like Twitter, Facebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock.